News

Afectair is a series of proprietary ventilator circuit patient interface connectors, that eases the delivery of any inhaled therapies to critical care patients requiring ventilatory support. The in-vitro

Caduet is a fixed-dose combination of Atorvastatin-Amlodipine besylate indicated for patients suffering from both, high blood pressure and high levels of cholesterol. Ranbaxy Americas senior vice-president and regional

The Anapen 500mcg, produced by Lincoln Medical, is an epinephrine auto-injector used in the treatment of allergic reactions such as anaphylaxis. The Resuscitation Council of UK has recommended

Lixisenatide is an investigational once-daily GLP-1 peptide agonist, found to suppress glucagon secretion from pancreatic alpha cells and enhance insulin secretion by pancreatic beta cells. The 24-week randomised

Galvus (vildagliptin) is a DPP-4 inhibitor that blocks the breakdown of incretin hormones in the body that stimulate the pancreas to produce insulin. The approval is backed by

Bavituximab, a phosphatidylserine (PS)-targeting monoclonal antibody, acts by targeting PS and thereby enabling the immune system to recognise and fight the tumor. The randomised Phase II lung cancer

According to Acetylon, Sidera proved to be a suitable choice to meet its growing data needs owing to Sidera’s reliable and secure communications network and Internet Access Service.

According to the company, Solo helps in the management of its global depot network including receipt of clinical supplies and kits, dispatches, returns, warehouse movements and QA releases.

According to Pharmabiz, the studies involved the application of Malvern’s light scattering technologies in evaluating the formulation stability of Albucult and Recombumin. The teams applied the resolving capabilities